Posted on April 12th, 2013 by Logan Lafferty
"The aim of our study was to determine gender-specific average-risk screening adenoma detection rates and the prevalence of adenomas by location, size, shape, and degree of dysplasia in each gender from our prospective study on adenoma detection. Recent data in abstract form report ADRs for women exceeding 25 percent. We hypothesized that ADRs for women in our average-risk screening patients also would be at least 25 percent," said study lead author Michael B. Wallace, MD, MPH, FASGE, Mayo Clinic, Jacksonville, Florida.
Additional Coverage: Medical Xpress
You must be logged-in to the site to post a comment.